Pacific Biosciences Of California reported $37.24M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Agilent USD 475M 10M Jun/2026
Bruker USD 226.5M 12.4M Sep/2026
Danaher USD 2.16B 87M Sep/2026
General Electric Aerospace USD 1.09B 40M Sep/2026
Illumina USD 281M 8M Sep/2026
Myriad Genetics USD 122.3M 6.7M Dec/2025
Pacific Biosciences Of California USD 37.24M 25.68M Dec/2025
Quidel USD 182.7M 7M Sep/2026
Revvity USD 275.33M 3.25M Sep/2026
Roche Holding CHF 6.37B 908M Jun/2026
Standard Biotools USD 16.39M 2.22M Jun/2026
Thermo Fisher Scientific USD 1.86B 46M Sep/2026
Waters USD 398M 7M Sep/2026